Trials / Not Yet Recruiting
Not Yet RecruitingNCT05840133
Study of Long Non-coding RNA SNHG15 as a Novel Biomarker in HBV Associated HCC
The First Affliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 156 (estimated)
- Sponsor
- Qianfoshan Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
In this study, the investigators will detect the expression of HBV-related HCC biomarker lncRNA SNHG15 in tumor tissues and peripheral blood, to explore the specific molecular markers for the early diagnosis of HBV-related HCC.
Detailed description
Paired hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) and adjacent liver tissues were selected, and lncRNA SNHG15 was detected by RT-PCR. At the same time, healthy subjects were selected as the control group, and lncRNA SNHG15 in blood was detected by RT-PCR. At the same time, the correlation between lncRNA SNHG15 and the clinical data of patients, such as diagnosis, pathological grading, recurrence, metastasis and survival time was statistically analyzed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | No intervention was required for patients or control group in this study | The patient was treated normally and no intervention was required in this study |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2025-01-31
- Completion
- 2027-12-31
- First posted
- 2023-05-03
- Last updated
- 2023-05-03
Source: ClinicalTrials.gov record NCT05840133. Inclusion in this directory is not an endorsement.